United States: Home Health Prospective Payment System Update And Redesign: Part Deux?

Last Updated: July 16 2018
Article by Summer Swallow and Kathleen McDermott

In the home health proposed payment rule released July 2 (Proposed Rule), the Centers for Medicare & Medicaid Services (CMS) continues its efforts to alert on six proposed Medicare payment updates to put "patient-centered care over paperwork" and prioritize "value over volume."

Home Health Prospective Payment System (HH PPS) Redesign

Following sharp industry criticism of the agency's calendar year (CY) 2018 home health proposed payment redesign, the Home Health Groupings Model (HHGM), which was estimated to cost providers nearly $1 billion in reimbursements, CMS ultimately decided not to finalize the proposal. HHGM included case-mix methodology refinements and a change in the unit of payment from a 60-day episode of care to a 30-day period of care. In the Proposed Rule, CMS offers a refurbished HHGM, now renamed the Patient-Driven Grouping Model (PDGM) in recognition of what CMS describes as a more patient-driven approach to payment. The PDGM is in many ways similar to the HHGM proposed in CY 2018; however, in accordance with requirements in the Bipartisan Budget Act of 2018 (BBA of 2018), the PDGM is to be implemented in a budget-neutral way effective January 1, 2020.

The PDGM approach requires use of the 30-day period of care and eliminating the use of therapy service thresholds and placing patients into meaningful payment categories based on clinical characteristics and other patient information. The PDGM includes 216 payment groupings that result from combinations of classifications for 30-day periods in the following five categories:

  • Timing Classifications – "early" or "late" depending on when they occur within a sequence of 30-day periods. Only the first 30-day episode would qualify as "early"
  • Admission Source – "community" or "institutional" depending on what healthcare setting was utilized in the 14 days prior to home health
  • Clinical Grouping – based on the principal diagnosis, patients would be placed in one of six clinical groupings, including (a) musculoskeletal rehabilitation; (b) neuro/stroke rehabilitation; (c) wounds- post-op wound aftercare and skin/non-surgical wound care; (d) complex nursing interventions; (e) behavioral health care; (f) medication management, teaching, and assessment
  • Functional Levels – a patient's level of function would be designated as low, medium, or high based on Outcome and Assessment Information Sets (OASIS) items such as grooming, bathing, and transferring
  • Comorbidity Adjustment – based on the secondary diagnoses reported by the home health agency (HHA) on the home health claim form, the adjustment is broken out into three levels (no, low, and high) which, depending on category, can increase payment by up to 20%

CMS identifies certain anticipated behavior assumptions that would be taken into account in calculating proposed payment amounts, including that (1) HHAs will change their documentation and coding practices to put the highest paying diagnosis code as the principal diagnosis code in order to have the period placed into a higher-paying clinical group; (2) the number of co-morbidity adjustments (claims form allows for more to be listed than does OASIS) would increase overall payments; and (3) low-volume cases would receive more visits. CMS also solicits comments on the elimination of the split payment approach considering the shorter periods of care.

Citing recent stakeholder concerns regarding the provision of home health care for Medicare patients with chronic, complex conditions, CMS reiterates that outlier payments could provide payment to HHAs for those patients with higher resource use and that the patient's condition does not need to improve for home health services to be covered by Medicare.

CMS commits to providing additional resources to better evaluate the proposed PDGM, including (1) Home Health Claims-OASIS Limited Data Set (available upon request); (2) report on a technical expert panel's recommendations on the proposal (estimated to be available no later than April 1, 2019); and (3) PDGM grouper to determine case-mix weights.

CY 2019 Payment Update

The Proposed Rule outlines CY 2019 payment updates that are estimated to yield $400 million (a net 2.1% increase) in increased payments to home health agencies. A net increase of 2.1% includes a 2.7% market basket update, productivity adjustment of -0.7%, 0.1% increase in high-cost outlier payments, and 0.1% decrease in payments due to the new statutorily mandated rural add-on methodology. The BBA of 2018 requires CMS to classify rural counties into one of three categories (high home health utilization, low population density, and all others) and vary the CYs 2019–2022 add-on payments based on counties' category classification.

Infusion Therapy

The Proposed Rule solicits comments related to the CY 2021 implementation of the new home infusion therapy benefit category, as established by the 21st Century Cures Act. The benefit covers the professional services including nursing services furnished in accordance with the plan of care, patient training, and education (not otherwise covered under the durable medical equipment benefit), remote monitoring, and monitoring services for the provision of home infusion therapy and home infusion drugs furnished by a qualified home infusion therapy supplier. As required by the BBA of 2018, the Proposed Rule would establish temporary transitional payments for certain home infusion therapy services in CYs 2019 and 2020. Additionally, the Proposed Rule offers health and safety standards for home infusion therapy including requirements for the plan of care to be initiated and updated by a physician; seven-day-a-week, 24-hour-a-day access to services, and remote monitoring; and patient education and training regarding their home infusion therapy care. These standards would provide the framework for CMS to establish an accreditation and oversight process for home infusion therapy suppliers.

Home Health Quality Reporting Program (HH QRP)

CMS invites comment on its proposal to replace the six criteria currently used when considering a quality measure for removal with the seven measure removal factors currently adopted in the other post-acute care quality reporting programs (LTCH QRP, IRF QRP, and SNF QRP) in addition to a new measure removal factor 8 (costs outweigh the benefit). For CY 2021, CMS proposes to remove the following seven quality measures from the HH QRP:

  • Depression Assessment Conducted
  • Diabetic Foot Care and Patient/Caregiver Education Implemented during All Episodes of Care
  • Multifactor Fall Risk Assessment Conducted for All Patients Who Can Ambulate
  • Pneumococcal Polysaccharide Vaccine Ever Received
  • Improvement in the Status of Surgical Wounds
  • Emergency Department Use without Hospital Readmission during the First 30 days of Home Health
  • Rehospitalization during the first 30 days of Home Health

Additionally, CMS clarifies that not all OASIS data currently collected would be required for the HH QRP beginning in CY 2020. CMS estimates the cost impact related to OASIS item collection as a result of the updated data collection processes for the PDGM and proposed changes to the HH QRP are estimated to result in a net $60 million in annualized cost savings to HHAs beginning in CY 2020.

Home Health Value-Based Purchasing Model (HHVBP)

CMS proposes to remove two OASIS based process measures (Influenza Immunization Received for Current Flu Season and Pneumococcal Polysaccharide Vaccine Ever Received) for CY 2019. Additionally, CMS would replace three measures (Improvement in Bathing, Improvement in Bed Transferring, and Improvement in Ambulation-Locomotion) with two composite measures (Total Normalized Composite Change in Self-Care and Total Normalized Composite Change in Mobility). CMS also proposes to reweight the measures used in the HHVBP Program (OASIS-based, claims-based, and HHCAHPS measures) to give more weight to claims-based measures in the hopes of incentivizing improved provider performance for those measures.

Remote Patient Monitoring

Referencing studies that tout the positive impact seen from allowing patients to share more real-time data with their providers and caregivers, CMS encourages providers' use of new technology to expand such practices. Advancing the administration's MyHealthEData initiative, CMS proposes to recognize the cost associated with "remote patient monitoring" as an allowable administrative cost on the Medicare cost report form. CMS defines "remote patient monitoring" as the collection of physiologic data (for example, ECG, blood pressure, glucose monitoring) digitally stored and/or transmitted by the patient and/or caregiver to the HHA.

Reduced Administrative Burden

CMS is proposing to eliminate the requirement that the certifying physician estimate how much longer skilled services would be needed when recertifying the need for continuing home health care, as the information is already gathered on a patient's plan of care. Additionally, CMS moves to align regulations and subregulatory guidance to allow medical record documentation from the HHA to be used to support the basis for certification and/or recertification of home health eligibility, provided certain requirements are met.

Comments are due no later than August 31, 2018.

This article is provided as a general informational service and it should not be construed as imparting legal advice on any specific matter.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions